Mangalam Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE584F01014
NSEID: MANGALAM
BSEID: 532637

INR

24.96

1.18 (4.96%)

BSENSE

Dec 29

BSE+NSE Vol: 2.64 lacs

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "24.96",
    "chg": 1.18,
    "chgp": "4.96%",
    "dir": 1,
    "prev_price": "23.78",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Dec 29",
    "curr_time": "",
    "bse_nse_vol": "2.64 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 29, 2025",
    "traded_date_str": "2025 12 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3773605",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_upper_circuit_3773605.png",
        "date": "2025-12-29 15:00:09",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 29 Dec 2025, closing at ₹24.96, marking a maximum daily gain of 4.96%. The pharmaceutical company witnessed robust buying interest, driving the stock to its highest intraday price in recent sessions despite a backdrop of subdued sector performance and falling investor participation."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Falls to 52-Week Low of Rs.22.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-falls-to-52-week-low-of-rs227-3773205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3773205.png",
        "date": "2025-12-29 10:15:49",
        "description": "Mangalam Drugs and Organics Ltd has touched a new 52-week low of Rs.22.7 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its business metrics and valuation."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3771043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_mojoScore_3771043.png",
        "date": "2025-12-26 15:13:06",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.08 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-stock-hits-52-week-low-amidst-continued-downtrend-3770508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3770508.png",
        "date": "2025-12-26 10:41:48",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low of Rs.23.08 today, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-52-week-low-amidst-continued-financial-struggles-3765345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3765345.png",
        "date": "2025-12-22 09:41:33",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low of Rs.23.45, marking a significant decline in its stock price amid ongoing financial pressures and sector headwinds. This level reflects a substantial drop from its 52-week high of Rs.129.90, underscoring the challenges faced by the pharmaceutical company over the past year."
      },
      {
        "title": "Why is Mangalam Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mangalam-drugs-fallingrising-3764276",
        "imagepath": "",
        "date": "2025-12-20 02:20:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downward Momentum Reflects in Price and Returns</strong></p>\n<p>The stock closed at ₹24.05, down by ₹0.24 or 0.99% as of 08:33 PM on 19-Dec, edging closer to its 52-week low of ₹23.77, just 1.16% away. This recent fall is part of a broader negative trend, with the share price having declined by 4.79% over the past week. This contrasts sharply with the Sensex, which recorded a marginal decline of 0.40% in the same period, highlighting Mangalam Drugs’ relative weakness.</p>\n<p>Over longer horizons, the underperformance is even more pronounced. The stock has plummeted by 55.96% in the last month and an alarming 79.26% year-to-date, while the Sensex has gained 8.69% over the same timeframe. The one-year and three-year returns for Mangalam Drugs are similarly dismal, with losses exceed..."
      },
      {
        "title": "Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-hits-lower-circuit-amid-heavy-selling-pressure-3753915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_stocks_hitting_lower_circuit_3753915.png",
        "date": "2025-12-09 12:00:08",
        "description": "Mangalam Drugs and Organics Ltd witnessed a sharp decline on 9 December 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at a new 52-week low of ₹23.55, marking a significant daily loss and reflecting a broader sentiment of panic selling among investors."
      },
      {
        "title": "Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.77",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-stock-hits-52-week-low-amidst-continued-downtrend-3753862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugsan_priceRelatedfactors_3753862.png",
        "date": "2025-12-09 11:45:33",
        "description": "Mangalam Drugs and Organics has reached a new 52-week low price of Rs.23.77, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and broader market indices, reflecting persistent challenges in its financial performance and market valuation."
      },
      {
        "title": "Mangalam Drugs Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3750080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MangalamDrugs_mojoScore_3750080.png",
        "date": "2025-12-07 10:10:21",
        "description": "Mangalam Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company's current standing amid a difficult market environment and deteriorating fundamentals."
      }
    ],
    "total": 138,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "details": "Mangalam Drugs And Organics Limitedalam Drugs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limitedgs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Clarification - Financial Results",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Other General Purpose",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2025-12-29 15:00:09

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 29 Dec 2025, closing at ₹24.96, marking a maximum daily gain of 4.96%. The pharmaceutical company witnessed robust buying interest, driving the stock to its highest intraday price in recent sessions despite a backdrop of subdued sector performance and falling investor participation.

Mangalam Drugs and Organics Ltd Falls to 52-Week Low of Rs.22.7

2025-12-29 10:15:49

Mangalam Drugs and Organics Ltd has touched a new 52-week low of Rs.22.7 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its business metrics and valuation.

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2025-12-26 15:13:06

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.08 Amidst Continued Downtrend

2025-12-26 10:41:48

Mangalam Drugs and Organics has reached a new 52-week low of Rs.23.08 today, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning.

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.45

2025-12-22 09:41:33

Mangalam Drugs and Organics has reached a new 52-week low of Rs.23.45, marking a significant decline in its stock price amid ongoing financial pressures and sector headwinds. This level reflects a substantial drop from its 52-week high of Rs.129.90, underscoring the challenges faced by the pharmaceutical company over the past year.

Why is Mangalam Drugs falling/rising?

2025-12-20 02:20:17

Persistent Downward Momentum Reflects in Price and Returns

The stock closed at ₹24.05, down by ₹0.24 or 0.99% as of 08:33 PM on 19-Dec, edging closer to its 52-week low of ₹23.77, just 1.16% away. This recent fall is part of a broader negative trend, with the share price having declined by 4.79% over the past week. This contrasts sharply with the Sensex, which recorded a marginal decline of 0.40% in the same period, highlighting Mangalam Drugs’ relative weakness.

Over longer horizons, the underperformance is even more pronounced. The stock has plummeted by 55.96% in the last month and an alarming 79.26% year-to-date, while the Sensex has gained 8.69% over the same timeframe. The one-year and three-year returns for Mangalam Drugs are similarly dismal, with losses exceed...

Mangalam Drugs and Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-09 12:00:08

Mangalam Drugs and Organics Ltd witnessed a sharp decline on 9 December 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at a new 52-week low of ₹23.55, marking a significant daily loss and reflecting a broader sentiment of panic selling among investors.

Mangalam Drugs and Organics Falls to 52-Week Low of Rs.23.77

2025-12-09 11:45:33

Mangalam Drugs and Organics has reached a new 52-week low price of Rs.23.77, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and broader market indices, reflecting persistent challenges in its financial performance and market valuation.

Mangalam Drugs Sees Revision in Market Assessment Amidst Challenging Financials

2025-12-07 10:10:21

Mangalam Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company's current standing amid a difficult market environment and deteriorating fundamentals.

View All News

Announcement

Mangalam Drugs And Organics Limited - Reply to Clarification- Financial results

09-Dec-2019 | Source : NSE

Mangalam Drugs And Organics Limitedalam Drugs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mangalam Drugs And Organics Limited - Clarification - Financial Results

21-Nov-2019 | Source : NSE

Mangalam Drugs And Organics Limitedgs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mangalam Drugs And Organics Limited - Other General Purpose

15-Nov-2019 | Source : NSE

Mangalam Drugs And Organics Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.